Zobrazeno 1 - 10 of 84 pro vyhledávání: '"Charlien Berghen"'
1
Akademický článek
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study
Autor: Valérie Fonteyne MD, PhD, Willeke Danckaert Msc, Piet Ost MD, PhD, Charlien Berghen MD, PhD, Katrien Vandecasteele MD, PhD, Ben Vanneste MD, PhD, Kato Rans MD, Nick Liefhooghe MD, Steven Wallaert Msc, Leen Paelinck PhD
Publikováno v: Technology in Cancer Research & Treatment, Vol 22 (2023)
Objectives: The aim is to evaluate the incidental dose to the lymphatic regions in prostate-only radiotherapy (PORT) and to compare hematological outcome between PORT and whole pelvic radiotherapy (WPRT) in node-positive prostate cancer (pN1 PCa), in
Externí odkaz: https://doaj.org/article/e0bdffbebfa342a88ad485fa5adccc24
Zobrazit plný text záznamu
2
Akademický článek
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial
Autor: Flor Verghote, Lindsay Poppe, Sofie Verbeke, Piet Dirix, Maarten Albersen, Gert De Meerleer, Charlien Berghen, Piet Ost, Geert Villeirs, Pieter De Visschere, Kathia De Man, Daan De Maeseneer, Sylvie Rottey, Charles Van Praet, Karel Decaestecker, Valérie Fonteyne
Publikováno v: BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background The outcome of patients with muscle-invasive bladder cancer (MIBC) remains poor, despite aggressive treatments. Inadequate primary staging, classically performed by computed tomography (CT)-imaging, could lead to inappropriate tre
Externí odkaz: https://doaj.org/article/bb6642d943504af999d236b8d42f9b98
Zobrazit plný text záznamu
3
Akademický článek
Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer
Autor: Niloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, Christophe M. Deroose, Koen Van Laere, Liesbeth De Wever, Cindy Mai, Charlien Berghen, Gert De Meerleer, Karin Haustermans, Steven Joniau, Wouter Everaerts, Karolien Goffin
Publikováno v: EJNMMI Research, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Background Detection of the site of recurrence using PSMA-PET/CT is important to guide treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this study was to evaluate the positivity rate of [18F]PSMA-1007-PE
Externí odkaz: https://doaj.org/article/ed8ec9e45ecf44c9b2078faeac5a5ed2
Zobrazit plný text záznamu
4
Akademický článek
Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial
Autor: Charlien Berghen, Steven Joniau, Kato Rans, Gaëtan Devos, Kenneth Poels, Koen Slabbaert, Herlinde Dumez, Maarten Albersen, Karolien Goffin, Karin Haustermans, Gert De Meerleer
Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Patients diagnosed with metastatic castration-refractory prostate cancer (mCRPC) rely on a limited number of therapeutic agents resulting in a median survival of 2–3 years. A subgroup of those patients with mCRPC presents with o
Externí odkaz: https://doaj.org/article/90060c59a5e04c95a2b431df7cfb5a3f
Zobrazit plný text záznamu
5
Akademický článek
Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer
Autor: Gaëtan Devos, Tim Muilwijk, Yannic Raskin, Victor Calderon, Lisa Moris, Thomas Van den Broeck, Charlien Berghen, Gert De Meerleer, Maarten Albersen, Hendrik Van Poppel, Wouter Everaerts, Steven Joniau
Publikováno v: Frontiers in Oncology, Vol 9 (2019)
Introduction: Salvage lymph node dissection (sLND) has been proposed as a treatment option for prostate cancer patients with lymph node (LN) recurrence following radical prostatectomy to delay or avoid palliative androgen deprivation therapy (ADT). H
Externí odkaz: https://doaj.org/article/d33a69a31ea74897accaffbcb345934f
Zobrazit plný text záznamu
6
Akademický článek
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
Autor: Rans, Kato1 (AUTHOR) kato.rans@uzleuven.be, Charlien, Berghen1 (AUTHOR), Filip, Ameye2 (AUTHOR), Olivier, De Hertogh3 (AUTHOR), Julie, den Hartog1 (AUTHOR), Céderic, Draulans1 (AUTHOR), Herlinde, Dumez4 (AUTHOR), Benedikt, Engels5 (AUTHOR), Karolien, Goffin6 (AUTHOR), Annouschka, Laenen7 (AUTHOR), Nick, Liefhooghe8 (AUTHOR), Kenneth, Poels1 (AUTHOR), Carl, Salembier9 (AUTHOR), Koen, Slabbaert10 (AUTHOR), Hans, Vandendriessche11 (AUTHOR), Ben, Vanneste12 (AUTHOR), Steven, Joniau13 (AUTHOR), Gert, De Meerleer1 (AUTHOR)
Publikováno v: BMC Cancer. 12/15/2022, Vol. 22 Issue 1, p1-10. 10p.
Zobrazit plný text záznamu
7
Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy
Autor: Henri Van Eecke, Gaëtan Devos, Bram Vansevenant, Arthur Vander Stichele, Wout Devlies, Charlien Berghen, Wouter Everaerts, Gert De Meerleer, Steven Joniau
Publikováno v: International Journal of Urology. 30:92-99
Several retrospective studies have shown that salvage bilateral pelvic lymph node dissection (sLND) is a valid treatment option in the setting of oligorecurrent nodal prostate cancer following radical prostatectomy. Little is known about the optimal
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa6a1de2afa95c54aae194547da7d7b
https://doi.org/10.1111/iju.15066
Zobrazit plný text záznamu
8
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study
Autor: Valérie Fonteyne, Willeke Danckaert, Piet Ost, Charlien Berghen, Katrien Vandecasteele, Ben Vanneste, Kato Rans, Nick Liefhooghe, Steven Wallaert, Leen Paelinck
Objectives: The aim is to evaluate the incidental dose to the lymphatic regions in prostate-only radiotherapy (PORT) and to compare hematological outcome between PORT and whole pelvic radiotherapy (WPRT) in node-positive prostate cancer (pN1 PCa), in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7ae42142933985219e2e98ab538a13f
https://lirias.kuleuven.be/handle/20.500.12942/718760
Zobrazit plný text záznamu
10
Current and emerging therapies for localized high-risk prostate cancer
Autor: Charlien Berghen, Wouter Everaerts, Wout Devlies, Thomas Van den Broeck, Maarten Albersen, Lisa Moris, Hendrik Van Poppel, Gaëtan Devos, T. Gevaert, Frank Claessens, Gert De Meerleer, Steven Joniau, Daimantas Milonas
Publikováno v: Expert Review of Anticancer Therapy. 21:267-282
Introduction: Despite progress in the field of high-risk localized prostate cancer (HRPCa) treatments, high-risk patients treated with curative intent are at increased risk of biochemical recurrence, metastatic progression and cancer-related death. T
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5625a7fe45884dac6256dedc94c8cbbf
https://doi.org/10.1080/14737140.2021.1852932
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje